Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 5 Adjusted association between the outcomes of interest and selected covariates

From: No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users

 

Alcohol vs METH (reference)

Cannabis vs METH (reference)

OR (95% CI)

P value

OR (95% CI)

P value

ICU LOS: RC (95% CI)

-0.69 (-3.15, 1.77)

0.55

-0.2 (-2.24, 1.83)

0.83

Interval between SARS-CoV-2 positive test and discharge: RC (95% CI)

-0.35 (-0.88, 0.18)

0.20

0.45 (-0.05, 0.94)

0.079

ICU admission

1.62 (0.21, 12.28)

0.69

1.3 (0.28, 6.11)

0.98

Mortality

1.26 (0.15, 10.64)

0.69

0.72 (0.11, 4.8)

0.61

Delirium

0.32 (0.05, 2.14)

0.068

2.14 (0.38, 11.98)

0.079

Intubation

0.26 (0.02, 2.75)

0.21

0.93 (0.16, 5.49)

0.44

  1. Adjusted for: Age, Sex, Vaccination before hospital admission, tobacco use, psych symptoms AMS, alcohol related disorders, stimulant usage, benzodiazepines s given
  2. RC Regression coefficient, OR Odds ratio, CI Confidence interval, ICU Intensive care unit
Back to article page

Journal of Cannabis Research

ISSN: 2522-5782